Search Results - "Poon, T P"

Circulating microRNAs as specific biomarkers for breast cancer detection by Ng, Enders K O, Li, Rufina, Shin, Vivian Y, Jin, Hong Chuan, Leung, Candy P H, Ma, Edmond S K, Pang, Roberta, Chua, Daniel, Chu, Kent-Man, Law, W L, Law, Simon Y K, Poon, Ronnie T P, Kwong, Ava

“…We previously showed microRNAs (miRNAs) in plasma are potential biomarkers for colorectal cancer detection. Here, we aimed to develop specific blood-based…”
Get full text

Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma by Xu, Michelle Z., Yao, Tzy‐Jyun, Lee, Nikki P. Y., Ng, Irene O. L., Chan, Yuk‐Tat, Zender, Lars, Lowe, Scott W., Poon, Ronnie T. P., Luk, John M.

“…BACKGROUND: Yes‐associated protein (YAP), a downstream target of the Hippo signaling pathway, was recently linked to hepatocarcinogenesis in a mouse…”
Get full text

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma by Chew, Valerie, Chen, Jinmiao, Lee, Deming, Loh, Evelyn, Lee, Joyce, Lim, Kiat Hon, Weber, Achim, Slankamenac, Ksenija, Poon, Ronnie T P, Yang, Henry, Ooi, London Lucien P J, Toh, Han Chong, Heikenwalder, Mathias, Ng, Irene O L, Nardin, Alessandra, Abastado, Jean-Pierre

“…Hepatocellular carcinoma (HCC) is a heterogeneous disease with poor prognosis and limited methods for predicting patient survival. The nature of the immune…”
Get more information

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma by Omata, Masao, Lesmana, Laurentius A., Tateishi, Ryosuke, Chen, Pei-Jer, Lin, Shi-Ming, Yoshida, Haruhiko, Kudo, Masatoshi, Lee, Jeong Min, Choi, Byung Ihn, Poon, Ronnie T. P., Shiina, Shuichiro, Cheng, Ann Lii, Jia, Ji-Dong, Obi, Shuntaro, Han, Kwang Hyub, Jafri, Wasim, Chow, Pierce, Lim, Seng Gee, Chawla, Yogesh K., Budihusodo, Unggul, Gani, Rino A., Lesmana, C. Rinaldi, Putranto, Terawan Agus, Liaw, Yun Fan, Sarin, Shiv Kumar

“…Introduction The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the management of hepatocellular…”
Get full text

Differentiating Early and Late Recurrences After Resection of HCC in Cirrhotic Patients: Implications on Surveillance, Prevention, and Treatment Strategies by Poon, Ronnie T. P.

Get full text

Treatment strategy for recurrent hepatocellular carcinoma: Salvage transplantation, repeated resection, or radiofrequency ablation? by Chan, Albert C. Y., Chan, See Ching, Chok, Kenneth S. H., Cheung, Tan To, Chiu, Dai Wing, Poon, Ronnie T. P., Fan, Sheung Tat, Lo, Chung Mau

“…The objective of this study was to evaluate the efficacy of salvage liver transplantation (SLT), repeated hepatic resection (RR), and repeated radiofrequency…”
Get full text

Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer by Poon, Ronnie T P, Borys, Nicholas

“…Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death worldwide. No more than 30% of HCC patients receive curative treatment. Factors…”
Get more information

Liver Transplantation for Hepatocellular Carcinoma by Mazzaferro, Vincenzo, Chun, Yun Shin, Poon, Ronnie T. P., Schwartz, Myron E., Yao, Francis Y., Marsh, J. Wallis, Bhoori, Sherrie, Lee, Sung-Gyu

“…Background Orthotopic liver transplantation (OLT) is the best available option for early hepatocellular carcinoma (HCC), although its application is limited by…”
Get full text

Identification of local and circulating cancer stem cells in human liver cancer by Yang, Zhen Fan, Ngai, Patricia, Ho, David W., Yu, Wan Ching, Ng, Michael N.P., Lau, Chi Keung, Li, Mandy L. Y., Tam, Ka Ho, Lam, Chi Tat, Poon, Ronnie T. P., Fan, Sheung Tat

“…Increasing evidence has revealed the importance of cancer stem cells (CSCs) in carcinogenesis. Although liver CSCs have been identified in hepatocellular…”
Get full text

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4–AKT–ATP‐binding cassette G2 pathway by Wang, Xiao Qi, Ongkeko, Weg M., Chen, Lin, Yang, Zhen Fan, Lu, Ping, Chen, Kwok Kin, Lopez, Jay P., Poon, Ronnie T.P., Fan, Sheung Tat

“…Chemoresistance presents a major obstacle to the efficacy of chemotherapeutic treatment of cancers. Using chemotherapeutic drugs to select drug‐resistant…”
Get full text

Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma by Chan, Albert C. Y., Poon, Ronnie T. P., Cheung, Tan To, Chok, Kenneth S. H., Chan, See Ching, Fan, Sheung Tat, Lo, Chung Mau

“…Background Tumor recurrence after resection of hepatocellular carcinoma is a common phenomenon. Re-resection and radiofrequency ablation (RFA) are good options…”
Get full text

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma by CHUNG MAU LO, CHI LEUNG LIU, SEE CHING CHAN, CHI MING LAM, POON, Ronnie T. P, NG, Irene L, SHEUNG TAT FAN, WONG, John

“…We conducted a randomized controlled trial of adjuvant interferon therapy in patients with predominantly hepatitis B-related hepatocellular carcinoma (HCC) to…”
Get full text

A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma by Ng, Kevin T P, Guo, Dong Yong, Cheng, Qiao, Geng, Wei, Ling, Chang Chun, Li, Chang Xian, Liu, Xiao Bing, Ma, Yuen Yuen, Lo, Chung Mau, Poon, Ronnie T P, Fan, Sheung Tat, Man, Kwan

“…Hepatocellular carcinoma (HCC) is highly malignant and metastatic. Currently, there is no effective chemotherapy for patients with advanced HCC leading to an…”
Get full text

Randomized clinical trial of hepatic resection versus radiofrequency ablation for early‐stage hepatocellular carcinoma by Ng, K. K. C., Chok, K. S. H., Chan, A. C. Y., Cheung, T. T., Wong, T. C. L., Fung, J. Y. Y., Yuen, J., Poon, R. T. P., Fan, S. T., Lo, C. M.

“…Background Hepatic resection and radiofrequency ablation (RFA) are treatment options for early‐stage hepatocellular carcinoma (HCC). Whether tumour recurrence…”
Get full text

Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria by Fan, S. T., Poon, R. T. P., Yeung, C., Lam, C. M., Lo, C. M., Yuen, W. K., Ng, K. K. C., Liu, C. L., Chan, S. C.

“…Background: There is a trend to offer liver transplantation to patients with hepatocellular carcinoma (HCC) with tumour status within the Milan criteria but…”
Get full text

Recurrence of Hepatitis B-Related Hepatocellular Carcinoma Is Associated With High Viral Load at the Time of Resection by HUNG, Ivan F. N, POON, Ronnie T. P, LAI, Ching-Lung, FUNG, James, FAN, Sheung-Tat, YUEN, Man-Fung

“…To identify the risk factors for recurrence of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after resection. Seventy-two patients who…”
Get full text

Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines by Wang, Xiao Qi, Ng, Ray Kit, Ming, Xiaoyan, Zhang, Wu, Chen, Lin, Chu, Andrew C Y, Pang, Roberta, Lo, Chung Mau, Tsao, Sai Wah, Liu, Xuqing, Poon, Ronnie T P, Fan, Sheung Tat

“…Activation of the stem cell transcriptional circuitry is an important event in cancer development. Although cancer cells demonstrate a stem cell-like gene…”
Get full text

Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability by Cheung, Tan To, Poon, Ronnie T P, Chok, Kenneth S H, Chan, Albert C Y, Tsang, Simon H Y, Dai, Wing Chiu, Chan, See Ching, Fan, Sheung Tat, Lo, Chung Mau

“…AIM:To analyze whether pancreaticoduodenectomy with simultaneous resection of tumor-involved vessels is a safe approach with acceptable patient…”
Get full text

Biology of Hepatocellular Carcinoma by Pang, Roberta W. C., Joh, Jae Won, Johnson, Philip J., Monden, Morito, Pawlik, Timothy M., Poon, Ronnie T. P.

“…Hepatocellular carcinoma (HCC) is a common cancer in the world due to high prevalence of hepatitis B or C virus infection. Research in recent years has…”
Get full text

Prognostic Marker MicroRNA-125b Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells Via Suppressing Tumorigenic Molecule eIF5A2 by Tsang, Felice H., Au, Victor, Lu, Wen-Jing, Shek, Felix H., Liu, Angela M., Luk, John M., Fan, Sheung-Tat, Poon, Ronnie T. P., Lee, Nikki P.

“…Background MicroRNAs (miRNAs) belong to a group of small non-coding RNA with differential expression in tumors, including hepatocellular carcinoma (HCC). Aim…”
Get full text